Skip to main content

Closed

BCYC: Bicycle Therapeutics plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-381.8%

ROIC-40.1%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-1194.1×

Current ratio12.66×

Bicycle Therapeutics plc

BCYCNASDAQ Global Select·USD·Closed

Bicycle Therapeutics plc

BCYCNASDAQ·USD·Closed

$3.86

−3.74%

$3.86

−$0.15 (3.74%)

52W Range

1thpctl

Volume

0.75×avg

Mkt Cap

267.86MUSD

P/E

-1.3TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.75×avg

Market Cap

267.86MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings